Duntumumab
|
WikiDoc Resources for Duntumumab |
|
Articles |
|---|
|
Most recent articles on Duntumumab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Duntumumab at Clinical Trials.gov Clinical Trials on Duntumumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Duntumumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Duntumumab Discussion groups on Duntumumab Patient Handouts on Duntumumab Directions to Hospitals Treating Duntumumab Risk calculators and risk factors for Duntumumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Duntumumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Duntumumab is a human monoclonal antibody and which it is used to treat cancer.